ANDA 71830, held by Warner Chilcott. Clorazepate Dipotassium.
As of Nov 15, 2026, ANDA 71830 (Clorazepate Dipotassium), held by Warner Chilcott, was first approved by FDA on Mar 3, 1988, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 3, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clorazepate Dipotassium15MG ยท tablet;oral | Clorazepate Dipotassium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
